Compare Medtronic PLC (MDT) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs AT&T Inc. — how do they compare? Medtronic PLC trades at $87.69 (market cap $109.38B), while AT&T Inc. trades at $23.27 (market cap $167.68B). The key difference: AT&T Inc. is the larger of the two by market cap, and AT&T Inc. pays the higher dividend (4.54%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and AT&T Inc. for 118 Days on average.
| MDT | T | |
|---|---|---|
Market Cap | $109.38B | $167.68B |
Volume | 55,890,185 | 27,788,850 |
Sector | Health | Media |
52-Week High | $105.35 | $29.10 |
52-Week Low | $73.75 | $20.49 |
Typical Hold Time | 63 Days | 118 Days |
Enterprise Value | $128.71B | $313.00B |
Dividend Yield | 3.37% | 4.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 0.76% on the day, with strong analyst support (60.78% buy ratings) and a $97.80 consensus price target suggesting 11.4% upside. The stock shows consistent earnings beats in recent quarters with Q3 2026 results pending, while technical indicators signal bearish momentum despite oversold RSI readings. Recent positive developments include FDA clearances for new medical technologies and a 49-year dividend growth streak with a current 3.2% yield.
MDT presents a compelling value opportunity with reasonable valuation multiples (P/E 21.06, P/S 2.93) and improving fundamentals, though technical weakness and competitive pressures warrant caution. The company's revenue growth acceleration to $33.54B in 2025 and strong cash flow generation support the dividend sustainability, while debt levels have increased to 31.11% of assets, representing a key monitoring point for investors.
AT&T (T) trades at $24.885, up 1.88% in the last session, with a bearish technical signal but strong fundamentals including a P/E of 8.08 and net income margin of 16.94%. Recent earnings beats and a $3 billion fiber deal with Corning highlight growth initiatives, while cash flow improved to $15.12B in 2025.
The stock offers value with a 4%+ dividend yield and analyst consensus price target of $27.61, but faces risks from high debt and competitive pressures. Upside depends on execution in fiber and wireless, while sentiment is mixed amid dividend sustainability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
